Trial site
Keio University Hospital
- 17running trials
- 14closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Bladder cancer3 trials
- Diffuse large B-cell lymphoma2 trials
- Endometrial cancer2 trials
- Kidney cancer2 trials
- Mild cognitive impairment2 trials
- Acute myeloid leukaemia1 trial
- Amyloidosis1 trial
- Bronchiectasis1 trial
- Cervical cancer1 trial
- Chronic kidney disease1 trial
- Colorectal cancer1 trial
- and 13 more
- Phase
- Phase 321 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 2/31 trial
- Status
- Completed13 trials
- Recruiting8 trials
- Active, not recruiting6 trials
- Not yet recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche9 trials
- Genmab2 trials
- Alfasigma S.p.A.1 trial
- argenx1 trial
- Astellas Pharma Global Development, Inc.1 trial
- and 17 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer
Active, not recruiting
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Amyloidosis1 recruiting
- Bronchiectasis1 recruiting
- Colorectal cancer1 recruiting
- Crohn's disease1 recruiting
- Cystic fibrosis1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Heart failure1 recruiting
- Multiple myeloma1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026